Reduction of Plasma Cholesterol by Lovastatin Normalizes Erythrocyte Membrane Fluidity in Patients with Severe Hypercholesterolaemia
Overview
Authors
Affiliations
The effect of lovastatin on erythrocyte membrane composition and fluidity was investigated in eight patients with severe hypercholesterolaemia (mean LDL-cholesterol of 7.2 mmol l-1). Lovastatin was administered at a dosage of 40-80 mg for 20 weeks and was discontinued for 5 weeks thereafter. Parallel to a 47% fall in plasma LDL cholesterol, there was a significant reduction (P < 0.01) in erythrocyte membrane cholesterol:phospholipid molar ratio, while erythrocyte membrane fluidity assessed by diphenylhexatriene (DPH) fluorescence polarization increased significantly (P < 0.01). Discontinuation of lovastatin resulted in the reversal of erythrocyte membrane composition and fluidity to pre-treatment values.
Salloum Z, Dauner K, Li Y, Verma N, Valdivieso-Gonzalez D, Almendro-Vedia V Elife. 2024; 13.
PMID: 38602170 PMC: 11186637. DOI: 10.7554/eLife.85964.
Phosphatidylethanolamine Is a Key Regulator of Membrane Fluidity in Eukaryotic Cells.
Dawaliby R, Trubbia C, Delporte C, Noyon C, Ruysschaert J, Van Antwerpen P J Biol Chem. 2015; 291(7):3658-67.
PMID: 26663081 PMC: 4751403. DOI: 10.1074/jbc.M115.706523.
Schaffer A, Verdoia M, Cassetti E, Barbieri L, Perrone-Filardi P, Marino P J Thromb Thrombolysis. 2015; 40(1):61-8.
PMID: 25680891 DOI: 10.1007/s11239-015-1174-x.
Uydu H, Yildirmis S, Orem C, Calapoglu M, Alver A, Kural B J Membr Biol. 2012; 245(11):697-705.
PMID: 22706680 DOI: 10.1007/s00232-012-9441-7.
Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis.
de Freitas M, de Oliveira M, Santos D, Mascarenhas Netto R, Fenelon S, Penha-Silva N J Membr Biol. 2010; 233(1-3):127-34.
PMID: 20146058 DOI: 10.1007/s00232-010-9232-y.